Search Results: All adjuvant trials found

Main Trials Page | Search Trials | Clinical Trial Site List | Drug Watch List

First-line Trials | Gleevec/Sutent-resistant | All Trials | Recruiting Trials | Preventative (Adjuvant)Treatment Trials

Note: The LRG uses ClinicalTrials.gov and other sources to compile the LRG Clinical Trials database. Click on the name (title) to see the trial details in the LRG database. Click on the NCT link (below) to see the trial details in ClinicalTrials.gov.

Drug	NCT#	Name	Phase	Status
Imatinib	NCT00025246	Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery	2	Ongoing

Imatinib	NCT00028002	Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor	2	Completed

Imatinib	NCT00041197	Imatinib Mesylate (Gleevec; STI571) in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed by Surgery	3	Ongoing

Imatinib	NCT00103168	Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor	3	Ongoing

Imatinib	NCT00116935	Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)	3	Ongoing

Imatinib	NCT00171977	Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)	4	Ongoing

Imatinib	NCT00278876	Adjuvant Imatinib in High-Risk GIST With c-Kit Mutation	2	Completed

Imatinib	NCT00500188	Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST	2	Ongoing

Imatinib	NCT00867113	Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)	2	Recruiting

9 Records found